Your search returned 7 results.

Results
	1.	Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer. [electronic resource] by Sasser, A Kate Sullivan, Nicholas J Studebaker, Adam W Hendey, Lindsay F Axel, Amy E Hall, Brett M Producer: 20071203 In: FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. [electronic resource] by Casneuf, Tineke Axel, Amy E King, Peter Alvarez, John D Werbeck, Jillian L Verhulst, Tinne Verstraeten, Karin Hall, Brett M Sasser, A Kate Producer: 20160219 In: Breast cancer (Dove Medical Press) vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. [electronic resource] by Sasser, A Kate Mundy, Bethany L Smith, Kristen M Studebaker, Adam W Axel, Amy E Haidet, Amanda M Fernandez, Soledad A Hall, Brett M Producer: 20071004 In: Cancer letters vol. 254 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Response to: Interference of daratumumab on the serum protein electrophoresis. [electronic resource] by McCudden, Christopher Axel, Amy E Slaets, Dominique Dejoie, Thomas Clemens, Pamela Frans, Sandy Bald, Jaime Plesner, Torben Jacobs, Joannes F M van de Donk, Niels W C J Moreau, Philippe Schecter, Jordan M Ahmadi, Tahamtan Sasser, A Kate Producer: 20170413 In: Clinical chemistry and laboratory medicine vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference. [electronic resource] by McCudden, Christopher Axel, Amy E Slaets, Dominique Dejoie, Thomas Clemens, Pamela L Frans, Sandy Bald, Jaime Plesner, Torben Jacobs, Joannes F M van de Donk, Niels W C J Moreau, Philippe Schecter, Jordan M Ahmadi, Tahamtan Sasser, A Kate Producer: 20170628 In: Clinical chemistry and laboratory medicine vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma. [electronic resource] by Casneuf, Tineke Xu, Xu Steven Adams, Homer C Axel, Amy E Chiu, Christopher Khan, Imran Ahmadi, Tahamtan Yan, Xiaoyu Lonial, Sagar Plesner, Torben Lokhorst, Henk M van de Donk, Niels W C J Clemens, Pamela L Sasser, A Kate Publication details: Blood advances Oct 2017 In: Blood advances vol. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. [electronic resource] by Nijhof, Inger S Casneuf, Tineke van Velzen, Jeroen van Kessel, Berris Axel, Amy E Syed, Khaja Groen, Richard W J van Duin, Mark Sonneveld, Pieter Minnema, Monique C Zweegman, Sonja Chiu, Christopher Bloem, Andries C Mutis, Tuna Lokhorst, Henk M Sasser, A Kate van de Donk, Niels W C J Producer: 20170731 In: Blood vol. 128 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)